)
Avanos Medical (AVNS) investor relations material
Avanos Medical Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
FY25 net sales reached $701 million, surpassing revised guidance, with adjusted diluted EPS at $0.94 and adjusted EBITDA at $87 million, driven by 6% organic growth in strategic segments.
Strategic focus on Specialty Nutrition Systems (SNS) and Pain Management & Recovery (PM&R) segments, supported by portfolio reshaping actions including divestitures and the acquisition of Nexus Medical.
Transformation initiatives are expected to deliver $15–$20 million in annualized savings by end of 2026.
Tariff mitigation initiatives are on track, with a full exit from China syringe manufacturing expected by June 2026.
Financial highlights
Q4 net sales were $180.9 million, up 0.7% year-over-year; full-year net sales rose 1.9% to $701.2 million.
Q4 adjusted diluted EPS was $0.29; adjusted EBITDA $28 million; adjusted gross margin 53.4%.
Full-year adjusted EBITDA was $86.8 million; adjusted gross margin for the year was 54.6%; adjusted SG&A as a percentage of revenue was 42%.
Free cash flow for the year was $43.1 million, down from $82.9 million prior year, but exceeded expectations due to timing of one-time charges and tax payments.
Outlook and guidance
2026 net sales expected between $700 million and $720 million; adjusted diluted EPS guidance for 2026 is $0.90–$1.10.
SNS segment projected to grow mid to high single digits organically; PM&R segment low to mid single digits.
Full-year tariff P&L costs expected to be ~$30 million, up $12 million from 2025, with majority impacting neonatal products.
Gross margin improvement anticipated in the second half of 2026 and into 2027 as tariff mitigation takes effect.
Capital expenditures for 2026 expected at $25 million, supporting supply chain initiatives.
Next Avanos Medical earnings date
Next Avanos Medical earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage